ABSTRACT The overall objective of this study was to provide 'semi-quantitative' or 'rigorous' definitions of the fluidity, lubricity and compactibility requirements of formulation for representative dosator and dosing disc capsule filling machines. To that end, model formulations were developed for those properties using Carr's compressibility index, ejection force, and plug breaking force at a specified compression force to gauge fluidity, lubricity, and compactibility, respectively. These formulations were each encapsulated on an Hofliger-Karg GKF-400 dosing disc machine and a Zanasi LZ-64 dosator machine. Each machine was instrumented to measure plug compression and ejection forces. The encapsulation process was evaluated for %CV of fill-weight, ejection force, plug breaking force and the dissolution of marker drugs incorporated in the formulations. The f 2 metric was used to compare dissolution profiles. The results suggest: (1) formulations should meet different flow criteria for successful encapsulation on the two machines, (2) a relatively lower level of lubricant may be sufficient for the dosing disc machine, (3) a higher degree of formulation compactibility is needed for the dosator machine, and (4) transferring formulations between these machine types (same class, different subclass per FDA's SUPAC-IR/MR Manufacturing Equipment Addendum) could be challenging. In certain cases dissolution profiles for the same formulation filled on the two machines with equivalent compression force were different based on f 2 < 50. Overall, the results of this study suggest a range of formulation characteristics appropriate for transferring formulations between these two types of machines.
INTRODUCTION A number of studies have been conducted looking at the interplay of various formulation and machine operating variables on specific types of automatic capsule filling machines. Of the 2 most common types of automatic filling machines, dosator machines (eg, MG2, Zanasi, Macofar) and dosing disc machines (eg, Hofliger-Karg [HK] , Bosch, and Harro-Hofliger), dosator machines have been studied most extensively. For example, an MG2 machine simulator was employed by Jolliffe and Newton. 1 Cole and May, 2 Small and Augsburger, 3 and Hogan and colleagues 4 are among the many investigators who have reported on research involving Zanasi filling machines. Britten and colleagues 5 conducted research with an apparatus that simulates the action of a Macofar dosator machine. Dosing disc machines used in studies have included HK or Bosch GKF machines. [6] [7] [8] However, no systematic study comparing the formulation requirements of dosator and dosing disc machines has been published. Such research would provide critical guidance to formulators concerned with 1 scaling up development batches to larger machines of a different type, 2 making postapproval equipment changes, or 3 developing formulations that would run on either type of equipment.
The objective of this study is thus to provide semiquantitative or rigorous definitions of the fluidity, lubricity, and compactibility requirements of formulations for dosator and dosing disc machines. To that end, sets of model formulations were developed that differed in their degree of fluidity, lubricity, or compactibility. Carr's compressibility index (CI), ejection force, and plug breaking force at a specified compression force were used to gauge fluidity, lubricity, and compactibility, respectively. Each model formulation was encapsulated on an HK GKF-400 dosing disc machine and a Zanasi LZ-64 dosator machine. Both machines were instrumented to monitor plug compression and ejection forces. The encapsulation process was evaluated on percent coefficient of variation (%CV) of fill weight, plug ejection force, plug breaking force, and dissolution of marker drugs incorporated in the test formulations. Encapsulation on the HK was performed at Novartis Pharmaceutical Corporation (East Hanover, NJ). 
MATERIALS AND METHODS

Materials
Methods
Development of Model Formulations
Model Flow Formulations CI was used as the flow criterion for the set of model flow formulations. CI can be calculated from the loose bulk density (LBD) and tapped bulk density (TBD) data using the following equation: 9 (1) LBD and TBD were estimated by the method described in the USP-NF supplement 10 using a Scott, Schaeffer, and White Paint Pigment Volumeter (Fisher Scientific, Springfield, NJ) that has a fixed volume receptacle of 16.39 cc. LBD was calculated from the weight of the powder and the volume of the receptacle. TBD was determined by using the Stampf Volumeter (J. Engelsman, Ludwigshafen, a Rh; Shandon Southern Instruments, Inc, Sewickley, PA).
To measure TBD, a predetermined weight of the material was loosely poured into a 100-mL volumetric cylinder. The volume of the powder was measured after the first 500 drops. The tapping was continued in steps of 100 drops until no further change in volume was observed. The difference in volume reduction noted after the first 500 drops was less than 2% on later drops. TBD was calculated from the weight and the tapped volume of the sample after 500 drops.
The goal was to develop formulations that differed in their fluidity, had similar compactibility and lubricant requirements, and could be processed on the encapsulation equipment. Therefore, the range of CIs selected was such that none of the formulations had either too much or too little fluidity. Several grades of Avicel, differing in particle size and not diluted with any glidants, exhibited a sufficiently broad range of CIs to provide an ideal set of model flow formulations. Since these grades differ in particle size and, thus, specific surface area, their lubricant requirements would be expected to differ slightly. However, microcrystalline cellulose, in general, has an exceptionally low lubrication requirement. No lubricant was added prior to encapsulation. The addition of a lubricant such as magnesium stearate would have altered both the fluidity and compactibility of these materials. Table 1 lists the LBDs, TBDs, CIs, and mean particle sizes 11 for the set of model flow formulations.
Model Lubricity Formulations
Ejection force was used as a measure of lubricity when developing the set of model lubricity formulations. Formulators commonly regard lactose, the most widely used filler in hard gelatin capsule formulations, to have a greater lubrication requirement than microcrystalline cellulose or Starch 1500. 3 Since the level of magnesium stearate was reported to have little or no effect on the compactibility of lactose plugs formed in a dosator machine (based on plug breaking force measurements), 12 blends of anhydrous lactose, dt grade, and magnesium stearate were used to create the model lubricity formulations. The blends were mixed for 5 minutes. A 0.47-L twinshell blender (Patterson Kelly Co Inc, E Stoudsburg, PA) was used and the batch size was 100 g. Plugs of capsule size no. 1 were made by using special tooling on a physical testing machine, Instron® 4502 (Instron Corp, Canton, MA), fitted with a 500-N load cell. Three plugs were made from each blend. The plugs weighed 300 mg and were compressed to the same length at a compression force of 200 ± 10 N. To confirm the lack of influence of magnesium stearate concentration on compactibility, the plug breaking forces were measured by using the same machine fitted with a 10-N load cell in a manner similar to that described by Davar and colleagues.
13 Table 2 lists Figure 1 . The binary mixtures of ascorbic acid DC 97 and Avicel PH 200 gave a suitably broad range of plug strengths and hence were chosen as the set of model compactibility formulations. These formulations exhibited a range of CIs from 12 to 20, indicating excellent to good fluidity. It was assumed that the ejection forces would differ only slightly from formulation to formulation depending on the ratio of ascorbic acid DC 97 to Avicel PH 200 in the formulation. Table 3 lists the set of model compactibility formulations. 14 and provided with digitized data acquisition.
Zanasi LZ-64
A previously instrumented Zanasi LZ-64 (IMA North America Inc, Fairfield, CT) was reinstrumented in a manner similar to that described by Small 14 and Botzolakis, 15 except that the data acquisition process was completely digitized. The necessary hardware and software for data acquisition were acquired from National Instruments (Austin, TX). The strain gauges and all other accessories used for installing strain gauges on the Zanasi LZ-64 size no. 1 piston were acquired from Micro-Measurements Division, Vishay Measurements Group Inc (Raleigh, NC).
Encapsulation of Model Formulations
The model formulations that were encapsulated on the instrumented HK GKF-400 and Zanasi LZ-64 are presented in Table 4 . All formulations were filled into size no. 1 capsules. A 4-kg batch was prepared for each model formulation.
Blending
When required, blending was carried out using a 15.2-L twin-shell blender (Patterson Kelly Co Inc). The blend times and procedures were the same as previously described, except in the case of the lubricity formulations in which 4% of a model lowsolubility drug, HCTZ, was incorporated. The model drug was included to study the possible impact of magnesium stearate concentration on dissolution and any differences in mixing during encapsulation that may exist between the 2 machine types. First, HCTZ was blended with anhydrous lactose for 5 minutes. The mixture thus formed was blended for 2 more minutes after the addition of magnesium stearate. The lubricant blend time was intentionally reduced from 5 minutes (used in developing the set of model lubricity formulations) to 2 minutes, to avoid possible overshearing of magnesium stearate in the larger batch.
Encapsulation on HK GKF-400
A dosing disc of 15 mm thickness was selected for all formulations. All 5 tamps were used for the model flow formulations, but only the first 4 tamps were used for the model lubricity and compactibility formulations. It was observed that the dosing disc cavities were completely filled after the first 4 tamps at the selected compression settings of approximately 100 and 200 N (adjusted on all 5 stations), while filling the model flow formulations. The powder bed height was kept constant at 35 mm, and the machine was operated at 50 strokes/min.
Encapsulation on Zanasi LZ-64
The formulations were filled first on the HK encapsulator. To achieve similar fill weights for each model formulation on the Zanasi filling machine, piston heights had to be adjusted for different formulations.
All formulations were run at compression forces of approximately 100 and 200 N. The powder bed height was kept constant at 50 mm and the machine was operated to fill approximately 38 capsules/min (using just 1 dosator).
Evaluation of the Encapsulation Process
Fill-Weight Variation
Filled capsules were weighed using a Mettler® balance (model AC 100; Mettler Instrument Corp, Hightstown, NJ), and a sample of 20 readings was used for calculating the average, SD, and %CV of fill weight. The empty hard gelatin capsule shells weighed 75 ± 1 mg.
Plug Breaking Force
Plug collection under the ejection station on both the Zanasi and the HK machines was facilitated by switching off the flow of capsules from the magazine to the bushings. For the plugs made on the HK, breaking force was measured on an Instron physical testing machine, as described by Davar and colleagues. 13 For the plugs made on the Zanasi, breaking force was measured using the tester previously constructed at UM and described by Shah et al. 6 Ten readings were averaged for each run. Although the principle of operation (3-point flexure) was the same for both testers, they employed different transducer types (strain gauge load cell for the Instron tester vs piezoelectric load cell for the UM tester). They also differed in the rate of movement of the blunt-edge blade used to break the plugs (0.55 mm/sec on the Instron tester vs 1.1 mm/sec on the UM tester). These differences may affect the absolute values of plug strengths recorded, but relative comparisons can be made for tests performed on the same tester.
Ejection Force
The instrumentation on both machines made possible the monitoring of ejection forces. Ten readings were averaged in each case.
Dissolution of Model Drugs
HCTZ and ascorbic acid were used as the marker drugs in the model lubricity and compactibility formulations, respectively. Dissolution of these marker drugs was carried out using the USP dissolution apparatus 2 (VanKel VK 6010; Vankel Industries Inc, Edison, NJ) at 50 rpm. The dissolution medium, 0.1 N HCl, was maintained at 37oC. A Beckman DU640 UV-VIS spectrophotometer (Beckman Industries Inc, Irvine, CA) was used to measure the absorbances. Samples at higher concentrations of ascorbic acid were diluted with the medium before measuring absorbances. Parameters for HCTZ were the following: the dissolution medium was 900 mL 0.1 N HCl; sampling time points were 2, 4 ,6, 8, 10, 15, 30, 45, 55, and 60 minutes; and the absorbance wavelength was 272 nm. Parameters for ascorbic acid were the following: the dissolution medium was 1000 mL 0.1 N HCl; sampling time points were 3, 5, 7, 10, 15, 30, 45, and 60 minutes; and the absorbance wavelength was 245 nm. (2) where Rt is the percentage dissolved at each time point for the reference formulation and Tt is the percentage dissolved at each time point for the test formulation. This method of comparing dissolution profiles was introduced by Moore and Flanner. 17 The similarity factor is 100 when the test and reference profiles are identical and approaches 0 as the dissimilarity increases. An f 2 value between 50 and 100 suggests that 2 dissolution profiles are similar and indicates a point-to-point difference of 10% or less. The dissolution profiles for the marker drugs used in the model formulations, HCTZ and ascorbic acid, were compared using this metric.
Particle Size Analysis
Particle size analysis was performed on the model compactibility formulations using a sonic sifter (AllenBradley Sonic Sifter; Fisher Scientific). The sieves (ATM Corp, Milwaukee, WI) used included nos. 30 (590 mm), 60 (250 mm), 80 (177 mm), 120 (125 mm), 170 (88 mm), and 200 (74 mm). A 5-g sample was sieved for 5 minutes at a pulse rate setting of 5 and an intensity setting of 5. The amount retained on each sieve was recorded. The cumulative percent oversize was estimated for each formulation.
RESULTS AND DISCUSSION
Flow Formulations
The ejection force, fill weight, and %CV of fill weight for the model flow formulations are tabulated in Tables 5(a) and (b) . Fill weights varied for different grades of Avicel compressed to similar compression forces, obviously due to differences in the particle size and bulk density of the different grades. The piston heights were adjusted on the Zanasi to provide fill weights similar to those observed with the HK machine. For the least free-flowing grade of Avicel, PH 101, a piston height of 20 mm had to be employed to achieve fill weights similar to those obtained on the HK encapsulator using a 15-mm dosing disc. The HK encapsulator is thus potentially more efficient than the Zanasi at filling relatively bulky materials such as Avicel PH 101. There is a greater %CV of compression force recorded for the more poorly flowing formulations on the HK encapsulator at tamping station no. 1. Shah and colleagues 6 made a similar observation and attributed this phenomenon to powder building up at station no. 5 and the ejection station upon rotation of the dosing disc, as well as to not having enough fluidity to distribute evenly to tamping station no. 1. This phenomenon did not affect fill weights.
In general, ejection forces increased as the particle size of the model flow formulations decreased ( Table  5 ; particle size of PH101<PH102<PH200). This observation most likely reflects the greater specific surface area and number of contact points the smaller particle size grades make with the dosing tube or dosing disc cavity surface. For both machines, ejection force also increased as the compression force employed increased, confirming previous observations. 3 It is interesting that the ejection forces recorded at equivalent compression forces for these unlubricated fillers were higher on the Zanasi machine than on the HK machine. For some of the comparisons, fill weights were slightly higher on the Zanasi machine, which suggests that those plugs were slightly longer and thus would present greater frictional resistance to ejection. However, higher ejection forces were also observed when fill weights were closely matched. Materials that can be run without lubricants often owe their low-lubricant requirement to postcompression elastic recovery that serves to reduce residual radial forces and probably reduces adhesion to confining walls. Britten and colleagues 5 discussed this phenomenon in the context of Starch 1500. On the basis of measurements made on an instrumented Macofar dosator machine simulator, Britten and colleagues 5 found for Starch 1500 plugs, which exhibit considerable elastic recovery, that residual radial pressure was lower than that for lactose and that the ejection pressures were undetectable. Microcrystalline cellulose, used as the model flow material, also exhibits substantial postcompression elastic recovery, 18 which at least in part accounts for this material's ability to be run without lubricant. However, in the present study, it is hypothesized that the gradual buildup of plugs in segments in the multiple-tamping process of the HK machine may allow for more complete postcompression elastic recovery, and hence lower ejection forces, than occurs on the Zanasi machine.
Lubricity Formulations
The ejection force, fill weight, plug breaking force, and %CV of fill weight estimated for the model lubricity formulations appear in Tables 6(a) and (b) for the HK GKF-400 and the Zanasi LZ-64, respectively. In general, ejection forces increased with the compression force employed. When encapsulating the model lubricity formulations on the Zanasi machine, it was observed that the ejection forces generally decreased with an increase in the concentration of magnesium stearate ( Figure 4 ). When encapsulating the same formulations on the HK machine, we observed that the ejection forces were not significantly influenced by the amount of magnesium stearate in the formulation. This finding could be attributed to the fact that the HK encapsulator employs a screw-fed hopper, the mixing action of which may cause sufficient coating of particles with magnesium stearate to compensate for differences in concentration. A related observation was made by Ullah and colleagues. 19 When transferring a formulation originally developed on a Zanasi machine to an HK GKF-1500, they found dissolution to be slower from the capsules filled on the HK machine. They proposed that shearing of the laminar magnesium stearate during the tamping step caused excessive coating of the formulation with the hydrophobic lubricant. They concluded that the problem could be overcome by reducing the initial level of lubricant from 1% to 0.3%. It is interesting that overmixing of magnesium stearate in the hopper of an MG2 dosator machine in which a rotating blade continuously mixes the powder also has been reported 20 ; the dissolution of 3 drugs (with 1% magnesium stearate) was reduced after 30 minutes of running the machine. The mixing or shearing sensitivity of magnesium stearate has been discussed. The absolute value of ejection force was generally higher on the Zanasi machine than on the HK machine for the same formulation. As discussed previously, materials that exhibit substantial elastic behavior may recover differently in the 2 machines, thereby leading to greater ejection forces in the dosator machine. While it is conceivable that such a theory could apply to the lactose-based model lubricity formulations, lactose exhibits substantially less elastic recovery than Starch 1500 5 and a substantially higher lubricant requirement than either Starch 1500 3, 5 or microcrystalline cellulose. 3 Clearly, any possible greater powder shearing in the dosing disc machine, as suggested by Ullah and colleagues, 19 would tend to increase the lubricant efficiency in that machine, thereby leading to easier ejection. Similar fill weights were attained on the Zanasi and HK machines, but a piston height of 18 mm had to be used on the Zanasi as compared to the dosing disc height of 15 mm used on the H&K. As noted previously, the multiple-tamp principle appears to be more efficient at densification than the single tamp of the dosator mechanism.
Table 6(a). Ejection force, fill weight, and plug breaking force recorded for the model lubricity formulations encapsulated on HK GKF-400
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Compactibility Formulations
The ejection force, fill weight, plug breaking force, and %CV of fill weight estimated from encapsulation of the model compactibility formulations are tabulated in Tables 7(a) and (b) for the HK GKF-400 and the Zanasi LZ-64, respectively. Table 7 (a). Ejection force, fill weight, and plug breaking force for the model compactibility formulations encapsulated on HK GKF-400 Table 7 (b). Ejection force, fill weight, and plug breaking force for the model compactibility formulations encapsulated on Zanasi LZ-64 Table 8 . CIs for the model compactibility formulations
The %CV of fill weight was comparatively low whenever a model compactibility formulation filled on the Zanasi machine included Avicel PH 200 in the formulation, regardless of the amount present ( Figure 5 ). This observation could be attributed to the cohesive and compressible nature (ie, compactibility) of microcrystalline cellulose that should contribute to the formation of a stable arch at the dosator open orifice 24 and the formation of mechanically strong plugs. In the Zanasi machine, where the bottom end of the plug is unsupported during plug transfer, formulation compactibility and the formation of stable arches are critical to quantitative plug transfer. When encapsulating model compactibility formulation C1 (containing no Avicel PH 200) on the Zanasi machine, it appeared that a portion of the bottom end of the plug was separating. In most cases, the lower ends of these plugs gave the appearance of having been chipped. The observed high %CV of fill weight is likely attributable at least in part to this phenomenon. On the HK machine, the %CV of fill weight for the compactibility formulations exhibited a minimum when the compression force used was approximately 200 N. Kurihara and Ichikawa 25 correlated a minimum in %CV of fill weight on an HK encapsulator to differences in the fluidity of the formulations. They observed that whenever the fluidity of the formulation was either above or below an optimum level based on angle of repose or minimum orifice diameter measurements, the %CV of fill weight was higher. CIs were estimated to compare the fluidity of the different model compactibility formulations and are tabulated in 25 and suggests that there is an optimum CI for best weight variation. Therefore, it can be said that neither excessive fluidity nor poor fluidity is desirable when filling formulations on the HK machine.
The pattern of %CV of fill weight for the model compactibility formulations when filled at 100 N cannot be explained by the same rationale. The compression force of 100 N may be too low to form stable powder arches from the mixtures of granular ascorbic acid DC 97 and Avicel PH 200, thus allowing loss of material during the transfer step. Relatively higher %CVs were observed for all formulations containing ascorbic acid DC 97. A piston height of 22 mm was used on the Zanasi to accommodate fill weights similar to those encapsulated on the HK. The fill weights decreased as the amount of ascorbic acid DC 97 decreased in the formulations ( Tables 7(a) and (b) ) because the granular ascorbic acid (DC 97) was denser and more free-flowing than Avicel PH 200. Even though all model compactibility formulations had the same level of lubricant (0.5%) blended for the same amount of time, ejection forces generally increased as the amount of Avicel PH 200 increased in the formulation. This pattern is attributed to changes in the particle size distribution of the binary mixtures of ascorbic acid DC 97 and Avicel PH 200. The particle size distribution is skewed to the higher end with greater amounts of ascorbic acid DC 97, thus reducing the overall surface area for coverage with the same concentration of lubricant and leading to lower ejection forces. Cumulative percent over-size plots comparing the particle size distributions of the model compactibility blends are shown in Figure 6 . The absolute values of the ejection forces again were relatively lower when the same formulation was filled on the HK machine. Possible explanations for this phenomenon have been discussed above. In general, plug breaking force increased with compression force proportionately for all formulations regardless of the machine used for encapsulation. The plug breaking force reached a minimum with the 50:50 mix of ascorbic acid DC 97 and Avicel PH 200. Unlike the plugs made on the Instron when developing the model compactibility formulations, the formulation containing ascorbic acid DC 97 without any Avicel PH 200 made plugs of measurable strength in the 2 filling machines. The plugs formed from the model compactibility formulations were stronger when all particles were of the same type. Dilution with a relatively compactible material like Avicel PH 200 often did not result in plugs of measurable strength, especially at a lower compression force. This behavior reflects the significance of interactions between like particles, and hence the minimums seen in Figures 7(a) and (b) . In general, plug breaking force increased with compression force. Since plug breaking forces were measured on 2 different testers, the absolute values might be different and may not be able to be compared fairly between the machines. Nevertheless, it is clear from Tables 6(a) and (b) that the plug breaking forces of the model lubricity formulations were not significantly influenced by the levels of magnesium stearate in the formulations. Table 9 lists the times for 60%, 75%, and 85% dissolution of HCTZ from the model lubricity formulations. It can be observed that the time taken for 85% dissolution (t85%) of HCTZ is not significantly influenced by either the compression force used or the amount of lubricant used (up to 0.5%) (Figure 8 ). At the 1%_magnesium stearate level, it was observed that the capsules filled on the Zanasi at 100 N exhibited a shorter t85% of HCTZ than those filled at 200 N. At 100 N, the plugs are possibly sufficiently soft for the dissolution of HCTZ to not be affected significantly by the level of magnesium stearate. Unlike for the formulations filled on the Zanasi machine, t85% of HCTZ from capsules filled on the HK machine at both 100 and 200 N were similar at each lubricant concentration. In addition, dissolution from the 1%_magnesium stearate formulation was the slowest among all formulations tested, regardless of the filling machine used. This slower dissolution and lack of influence of compression force on dissolution may be due to the combined effect of a higher 1% concentration and possible greater shearing of the lubricant in the HK machine. The latter may have overwhelmed any effect of compression force. Table 10 lists the times for 60%, 75%, and 85% dissolution of ascorbic acid from the model compactibility formulations. The dissolution of ascorbic acid was slowest from the formulation that did not contain any Avicel PH 200, as seen in Figure  9 comparing the t85%s of ascorbic acid from the model compactibility formulations. For those formulations containing Avicel PH 200, the microcrystalline cellulose may be acting as an in-situ disintegrant by promoting liquid uptake and swelling. 26 Also, as the binary mixtures were diluted with Avicel PH 200 (formulations C2, C3, and C4), the plug strength decreased, as discussed previously. This softening of the plugs could promote faster dissolution of ascorbic acid from these formulations. Dissolution of ascorbic acid from C1 appears to be slower when filled on the Zanasi. The plug was formed in multiple stages on the HK, and the plug segments may separate to speed up the initial stages of the dissolution process. The dissolution profiles of ascorbic acid from capsules filled on both machines were compared using the f 2 test. Table 11 lists the f 2 values estimated when comparing the ascorbic acid dissolution profiles for the same formulation filled on the 2 machines at the same compression force. There are 2 cases in which the f 2 value was less than 50, suggesting that the dissolution profiles for the same formulation differ on the 2 machines. Figure 10 displays 1 of these 2 dissolution profiles. Similarly, the dissolution profiles of HCTZ from capsules filled on both machines were compared using the f 2 test ( Table 12 ). For 1 set of conditions (Formula L3 at the 100-N compression force), the f 2 value was less than 50, again suggesting that the dissolution profiles for the same formulation differ on the 2 machines. The dissolution profiles are exhibited in Figure 11 . These differences in dissolution between the 2 machines indicated by the f 2 metric may not signify different product performance in vivo, as discussed by Polli and colleagues. 27 However, such results would suggest the need for a preapproval supplement if these were the outcome of a postapproval change in filling machines. According to the manufacturing equipment addendum to the SUPAC-IR and SUPAC-MR [modified release] guidances, the 2 types of capsule filling machines used in this study are members of the same class of machines but belong to different subclasses. 28 Equipment within the same class and subclass are considered to have the same design and operating principle under SUPAC-IR and SUPAC-MR. Provided certain other conditions are met, a postapproval change of manufacturing equipment between subclasses within the same class of equipment likely would not require a preapproval supplement. But the guidance also states that changes in equipment that are in the same class, but different subclasses, as is the case here, should be considered carefully and evaluated on a case-by-case basis. The SUPAC guidance places the burden on the applicant to provide the scientific data and rationale at the time of change to determine whether a preapproval supplement is justified. These data are subject to FDA review at its discretion.
Comparison of Dissolution Performance
CONCLUSION
The results of this study suggest that an optimal degree of fluidity is required in a formulation for successful encapsulation on either machine. In the present study, a CI value from 20 to 30 is an optimum value based on capsule weight variation. Of the 3 Avicel grades, the medium-flow grade, PH 102, seems to be the most suitable for transferring formulations between these machines.
A relatively lower level of lubricant may be sufficient for encapsulation on the HK machine as compared to the Zanasi, as evidenced by the ejection forces recorded during encapsulation of all model formulations.
The dissolution of the model drug, HCTZ, from capsules filled on the Zanasi machine was more affected by compression force at a higher level of magnesium stearate.
A higher degree of formulation compactibility may be needed for clean processing on the Zanasi machine as compared to the HK. This observation is reflected in the present study by the higher %CV for capsule weight recorded for the model compactibility formulation without Avicel PH 200. In general, higher compression forces resulted in stronger and more intact plugs on either machine. Higher compression forces may eliminate or reduce inefficient plug transfer.
Transferring formulations between machine types could be challenging in certain situations (eg, when the drug is hydrophobic or dose is very high with very low bulk density). It may be advisable to lower the level of laminar lubricants such as magnesium stearate when transferring formulations originally developed on Zanasi machines to HK machines, regardless of the hydrophobicity of the drug. For the materials and test conditions studied, it appears that the lubricant level could be reduced by as much as 50%.
In general, the multiple-tamping principle of the dosing disc machine may be more efficient in encapsulating a very bulky material into a given size capsule.
The f 2 test comparing the dissolution profiles suggested that in vitro dissolution of the same formulation differed on the 2 machines. Since these machines represent different subclasses, a preapproval supplement may be needed if this result were the outcome of a postapproval change.
In summary, the results of this study reveal important differences in formulation requirements between the Zanasi (dosator) and HK (dosing disc) machines. An understanding of these differences facilitates the design of optimal capsule formulations for such machines and provides guidance on making equipment changes within these types of machines.
